VRSCD Stock UPDATES Valterra Resource Co (VRSCD) 0.0250 08/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Valterra Resource Co (VRSCD) 0.0250 $VRSCD

Valterra to Hold Annual General Meeting
Marketwire - Mon Aug 18, 3:10PM CDT
Valterra Resource Corporation (the "Company" or "Valterra" (TSX VENTURE: VQA)(FRANKFURT: 3VA) announces that its annual general meeting of shareholders of the Company will be held at the Company's offices at Suite 1100, 1199 West Hastings Street, Vancouver, British Columbia on October 22, 2014 at 10:00 a.m.

Valterra Identifies New High-Grade Samples at the Bobcaygeon Graphite Project
Marketwire - Wed Jun 18, 7:32AM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) (the "Company" or "Valterra" reported today that new sampling from the Bobcaygeon graphite property located in southern Ontario, continues to expand and develop targeting at two prospects on the project.

Valterra Closes First Tranche of Financing
Marketwire - Wed Jun 11, 4:08PM CDT
Valterra Resource Corporation (the "Company" or "Valterra" (TSX VENTURE: VQA)(FRANKFURT: 3VA) has completed the first tranche of its previously announced private placement by issuing 1,000,000 units at a price of $0.05 per unit for gross proceeds of $50,000. Each unit consists of one common share and one share purchase warrant, with each warrant exercisable to purchase one additional common share at an exercise price of $0.05 for a period of 3 years. All securities issued in this tranche of the financing include a legend restricting trading of the securities until October 11, 2014. The private placement is subject to TSX Venture Exchange acceptance.

Valterra Closes First Tranche of Financing and Completes Debt Settlement; Insider Acquires Additional Securities
Marketwire - Thu Feb 20, 6:40PM CST
Valterra Resource Corporation ("Valterra" (TSX VENTURE: VQA)(FRANKFURT: 3VA) has completed the first tranche of its previously announced private placement by issuing 3,105,000 units at a price of $0.05 per unit for gross proceeds of $155,250. Each unit consists of one common share and one share purchase warrant, with each warrant exercisable to purchase one additional common share at an exercise price of $0.05 for a period of 3 years. All securities issued in this tranche of the financing include a legend restricting trading of the securities until June 21, 2014. The private placement is subject to TSX Venture Exchange acceptance.

Graphite Discovery with Valterra Resource, CEO Clip Video
Newsfile Corp - Fri Jun 21, 5:01AM CDT
full story)

Valterra Assays Up to 28.1% (Cg) Graphite from New Bobcaygeon Regional Prospects
Marketwire - Wed Jun 05, 8:31AM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) reports very encouraging grab and chip sampling results of up to 28.1% Cg from recent regional prospecting which identified three new graphite prospects located up to 23km on-strike from the Bobcaygeon Discovery Zone in Southern Ontario. Subsequently, new claims have been added to incorporate the zones into the property package. Finalized claim details are pending government agent processing.

Valterra Assays Ultra-High-Purity Flake Graphite of 99.97% at Bobcaygeon
Marketwire - Mon May 13, 8:02AM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) reports that metallurgical results from continued testing on the +20kg Discovery Zone trench sample from the Bobcaygeon Graphite Project in southern Ontario has produced an ultra-high-purity, fine-flake graphite concentrate of 99.97% C by LOI method.

Valterra Discovers New +1km-Long Graphite Trend at Bobcaygeon
Marketwire - Thu May 02, 1:28PM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) reports that a new +1km-long, NE-trending series of anomalous graphite samples, recently compiled from the Bobcaygeon Graphite Project in Southern Ontario, defines an open-ended, graphite-enriched corridor located approximately 1.5km north of the Discovery Zone (to see compilation map please click the following link: http://media3.marketwire.com/docs/ValtMap52.pdf).

Valterra Enters Into Investor Relations Agreement With Vanguard Shareholder Solutions Inc.
Marketwire - Wed Apr 03, 3:10PM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) ("Valterra" or the "Company" is pleased to announce the engagement of Vanguard Shareholder Solutions Inc. ("Vanguard" as an investor relations consultant, subject to acceptance by the TSX Venture Exchange.

Valterra Begins Drilling Graphite Targets at the Bobcaygeon Project
Marketwire - Mon Mar 25, 12:01PM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) reports that a diamond drill rig has been mobilized onsite and commenced coring at the +160 sq. km. Bobcaygeon Graphite Project in southern Ontario. The company is utilizing a portable 'Prospector 89' drill rig which is capable of drilling several near-surface targets recently identified by trenching, mapping and geophysical surveys. The primary focus is to test proximal zones to the Discovery Zone trench which has returned excellent metallurgical, analytical and geophysical results.

Valterra Returns High Purity Graphite Products; Including +99% C from Leach Testing at the Bobcaygeon Project
Marketwire - Thu Mar 21, 8:16AM CDT
Valterra Resource Corporation (TSX VENTURE: VQA)(FRANKFURT: 3VA) reports that preliminary metallurgical results from continued testing on the +20kg Discovery Zone trench sample from the Bobcaygeon Graphite Project in southern Ontario has produced medium, coarse and jumbo flake graphite fractions assaying greater than 94% C(t) by LOI and a high-purity fine flake graphite fraction, that with additional leaching, returned 99.14% C by double LOI in concentrate. These preliminary flotation and leaching test results demonstrate the potential to produce marketable, high-margin graphite products utilizing industry-standard processing techniques.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading